Patents by Inventor Ayako Okamura

Ayako Okamura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CLEANING OR HYDROPHILIZING AGENT COMPOSITION
    Publication number: 20230287301
    Abstract: Provided are a cleaning or hydrophilizing agent composition and a method for cleaning or hydrophilizing a hard surface excellent in cleaning power and capable of imparting hydrophilicity to hard surfaces. The cleaning or hydrophilizing agent composition contains (A) an anionic surfactant (hereinafter referred to as component (A)), (B) a nonionic surfactant (hereinafter referred to as component (B)) and water, wherein the composition contains (A1) a branched anionic surfactant as component (A), and (B1) a nonionic surfactant having a hydrocarbon group with 8 or more and 22 or less carbons as component (B).
    Type: Application
    Filed: November 17, 2020
    Publication date: September 14, 2023
    Applicant: Kao Corporation
    Inventors: Akari MENDORI, Takanori SAITO, Ayako OKAMURA
  • DETERGENT COMPOSITION
    Publication number: 20220325202
    Abstract: The present invention is a detergent composition containing (A) an anionic surfactant, (B) a nonionic surfactant and water, wherein the composition contains (A1) an anionic surfactant having a hydrocarbon group and as acid- or salt-form sulfonic acid group as component (A), and one or two or more nonionic surfactants selected from the group consisting of (B1-1) a nonionic surfactant having a linear hydrocarbon group with 8 or more and 10 or less carbons and (B1-2) a nonionic surfactant having a branched hydrocarbon group with 8 or more and 22 or less carbons as component (B).
    Type: Application
    Filed: November 17, 2020
    Publication date: October 13, 2022
    Applicant: KAO CORPORATION
    Inventor: Ayako OKAMURA
  • Cytotoxic T-cell epitope peptides that specifically attack epstein-barr virus-infected cells and uses thereof
    Patent number: 8481051
    Abstract: The present inventors introduced mRNAs for the Epstein-Barr virus proteins LMP1 and EBNA1 into antigen-presenting cells, and as a result, demonstrated that the cells induced Epstein-Barr virus-specific cytotoxic T cells. The present inventors also demonstrated that the cytotoxic T cells recognized epitope peptides presented via HLA-A*0206, HLA-Cw*0303, or HLA-Cw*0304, inhibited the outgrowth of Epstein-Barr virus-infected B cells, and lysed Epstein-Barr virus-infected NK lymphomas and NK cells.
    Type: Grant
    Filed: October 27, 2006
    Date of Patent: July 9, 2013
    Assignee: Medical and Biological Laboratories Co., Ltd.
    Inventors: Kiyotaka Kuzushima, Yoshinori Ito, Ayako Okamura, Yoshiki Akatsuka, Yasuo Morishima
  • CYTOTOXIC T-CELL EPITOPE PEPTIDES THAT SPECIFICALLY ATTACK EPSTEIN-BARR VIRUS-INFECTED CELLS AND USES THEREOF
    Publication number: 20090305324
    Abstract: The present inventors introduced mRNAs for the Epstein-Barr virus proteins LMP1 and EBNA1 into antigen-presenting cells, and as a result, demonstrated that the cells induced Epstein-Barr virus-specific cytotoxic T cells. The present inventors also demonstrated that the cytotoxic T cells recognized epitope peptides presented via HLA-A*0206, HLA-Cw*0303, or HLA-Cw*0304, inhibited the outgrowth of Epstein-Barr virus-infected B cells, and lysed Epstein-Barr virus-infected NK lymphomas and NK cells.
    Type: Application
    Filed: October 27, 2006
    Publication date: December 10, 2009
    Applicants: MEDICAL AND BIOLOGICAL LABORATORIES CO., LTD, AICHI PREFECTURE
    Inventors: Kiyotaka Kuzushima, Yoshinori Ito, Ayako Okamura, Yoshiki Akatsuka, Yasuo Morishima